NDC 0006-5086 – Prevymis
Letermovir 20 mg/1 · Pellet · Oral
Product NDC0006-5086
Product details
- Brand name
- Prevymis
- Generic name
- Letermovir
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- Pellet
- Route
- Oral
- Marketing category
- NDA · NDA219104
- Marketed since
- August 30, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- Cytomegalovirus DNA Terminase Complex Inhibitor
Active ingredients
- Letermovir 20 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0006-5086-01 | 30 PACKET in 1 CARTON (0006-5086-01) / 8 PELLET in 1 PACKET | Aug 30, 2024 |
Other Prevymis products
- 0006-5085 Letermovir 120 mg/1 · Pellet · Merck Sharp & Dohme LLC
- 0006-3075 Letermovir 240 mg/1 · Tablet, Film Coated · Merck Sharp & Dohme LLC
- 0006-3076 Letermovir 480 mg/1 · Tablet, Film Coated · Merck Sharp & Dohme LLC
- 0006-5003 Letermovir 20 mg/mL · Injection, Solution · Merck Sharp & Dohme LLC
- 0006-5004 Letermovir 20 mg/mL · Injection, Solution · Merck Sharp & Dohme LLC